Detalhe da pesquisa
1.
Multicenter Canadian case series of pediatric patients less than 12 years of age with moderate-to-severe atopic dermatitis treated with dupilumab.
Pediatr Dermatol
; 41(1): 5-11, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906120
2.
Spesolimab, A Novel Interleukin-36 Inhibitor for Generalized Pustular Psoriasis Flares in Adult Patients.
Skin Therapy Lett
; 29(1): 1-4, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271532
3.
Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up).
J Am Acad Dermatol
; 89(3): 478-485, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37230366
4.
The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity.
J Eur Acad Dermatol Venereol
; 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708097
5.
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway.
J Cutan Med Surg
; 27(1_suppl): 3S-24S, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519621
6.
Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
J Cutan Med Surg
; 27(6): 594-600, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37571829
7.
Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Adults.
Skin Therapy Lett
; 28(1): 1-6, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36657434
8.
Characterization of acne associated with upadacitinib treatment in patients with moderate-to-severe atopic dermatitis: A post hoc integrated analysis of 3 phase 3 randomized, double-blind, placebo-controlled trials.
J Am Acad Dermatol
; 87(4): 784-791, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714786
9.
Management of moderate-to-severe plaque psoriasis with biologics: A treat-to-target position paper.
Dermatol Ther
; 35(10): e15777, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35988045
10.
Halobetasol Propionate 0.01% Lotion for Plaque Psoriasis and Corticosteroid-Responsive Dermatoses.
Skin Therapy Lett
; 27(3): 1-4, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35533304
11.
Predictors of family impact of juvenile localized scleroderma.
Pediatr Dermatol
; 38(5): 1137-1142, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34263473
12.
Fixed Combination Halobetasol Propionate and Tazarotene Lotion for Plaque Psoriasis.
Skin Therapy Lett
; 26(6): 1-3, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871475
13.
Management of pediatric plaque psoriasis using biologics.
J Am Acad Dermatol
; 82(1): 213-221, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31150699
14.
Novel use of Autoinflammatory Diseases Activity Index (AIDAI) captures skin and extracutaneous features to help manage pediatric DITRA: A case report and a proposal for a modified disease activity index in autoinflammatory keratinization disorders.
Pediatr Dermatol
; 37(4): 670-676, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32301172
15.
Efficacy of brodalumab in moderate-to-severe plaque psoriasis after failure of previous biologic therapy: A phase 4, multicenter, open-label study.
J Am Acad Dermatol
; 90(6): 1254-1256, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290619
16.
Real-world experience of bimekizumab for adult patients with plaque psoriasis: A 16-week multicenter retrospective study.
J Am Acad Dermatol
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38649098
17.
Real-world effectiveness and safety of risankizumab in adult patients with plaque psoriasis: A 1-year international multicenter retrospective cohort study.
J Am Acad Dermatol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677338
18.
Pediatric leukemia cutis: A case series.
Pediatr Dermatol
; 36(5): 658-663, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31273836
19.
Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section III: Treatment Options for Pediatric Atopic Dermatitis.
J Cutan Med Surg
; 23(5_suppl): 19S-31S, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31692376
20.
Use of Janus Kinase Inhibitor Treatment for Palmoplantar Pustulosis: An Evidence-Based Review.
J Cutan Med Surg
; 28(1): 86-87, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37937880